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Copyright © 2009 AHC Bisphenol A (BPA) is a monomer use in manufacturing a wide range of chemical products
which include epoxy resins and polycarbonate. It has been reported that BPA increases the
cell proliferation activity of human breast cancer MCF-7 cells as well as 17-β estradiol (E2)
and diethylstilbestrol (DES). However, BPA induces target genes through ER-dependent and
ER-independent manners which are different from the actions induced by E2. Therefore,
BPA may be unique in estrogen-dependent cell proliferation compared to other endocrine
disrupting chemicals (EDCs). In the present study, to test whether ERα is essential to the
BPA-induced proliferation on MCF-7 cells, we suppressed the ERα expression of MCF-7
cells by RNA interference (RNAi). Proliferation effects in the presence of E2, DES and BPA
were not observed in ERα-knockdown MCF-7 cells in comparison with control MCF-7. In
addition, a marker of proliferative potential, MIB-1 labeling index (LI), showed no change in
BPA-treated groups compared with vehicle-treated groups on ERα-knockdown MCF-7 cells.
In conclusion, we demonstrated that ERα has a role in BPA-induced cell proliferation as well
as E2 and DES. Moreover, this study indicated that the direct knockdown of ERα using RNAi
serves as an additional tool to evaluate, in parallel with MCF-7 cell proliferation assay, for
potential EDCs.
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I. Introduction
Bisphenol A (BPA) is a known endocrine disrupting
chemical (EDC) that is a major component of epoxy and
polycarbonate resin, which is widely used as an ingredient in
the protective coatings on food containers and as adhesives
used in packaging products [1, 8, 16]. It has been reported
that BPA has weak estrogen activity approximately 1/1000-
to 1/10,000-fold of 17-β estradiol (E2) [29], and interacts
with estrogen receptors alpha (ERα) and beta (ERβ) [7, 10,
12]. Exposure of BPA induces the expression of progester-
one receptor, and promoted MCF-7 breast cancer cell prolif-
eration [9, 16, 21, 23, 25]. In experiments with rodents,
exposure of high doses of BPA has been reported to induce
reproductive toxicity and abnormal cellular development
[15].
Between the 1940s to the 1970s, diethylstilbestrol
(DES), a potent synthetic estrogen, was prescribed to pre-
vent complications of pregnancy [28]. Prenatal DES expo-
sure in women is known to cause genital abnormalities and
carcinomas [2]. Perinatal exposure of laboratory mice to
DES also elicits a spectrum of reproductive tract lesions
[13].
Estrogens regulate many physiological processes, in-
cluding normal cell proliferation, development, and tissue-
specific gene regulation in the reproductive tract and in the
central nervous and skeletal systems. Estrogens also influ-
ence the pathological processes of hormone-dependent dis-Miyakoshi et al. 24
eases, such as breast, endometrial, and ovarian cancers, as
well as osteoporosis. The biological actions of estrogens
are mediated by binding to one of two specific estrogen
receptors (ERs), ERα or ERβ, which belong to the nuclear
receptor superfamily [11, 31]. The biological significance
of the existence of two ERα and ERβ subtypes is at this
moment unclear [17, 18].
Studies on estrogenic effects of EDCs have been main-
ly performed by MCF-7 cell proliferation assay (E-screen
assay), ER reporter gene assay or yeast assays [3, 6, 25]. In-
terestingly, BPA exhibits characteristics of a distinct molec-
ular mechanism of action at ERα, with BPA interacting dif-
ferently within the ligand-binding domain compared with E2
[5]. In addition, BPA induces target genes through ER-
dependent and ER-independent manners which are different
from the actions induced by E2 [23, 24]. Therefore, BPA
may be unique in estrogen-dependent cell proliferation com-
pared to other EDCs. In the present study, to investigate
whether ERα participate in the BPA-induced cell prolifera-
tion as well as E2 and DES, we performed the suppression of
ERα expression in MCF-7 cells by RNAi.
II. Materials and Methods
Chemicals
17β-estradiol and diethylstilbestrol were purchased
from Wako Pure Chemicals Industries, Ltd. (Wako, Osaka,
Japan). Bisphenol A was purchased from Sigma-Aldrich
(Sigma, St Louis, MO, USA). The chemicals were solubi-
lized in dimethyl sulfoxide (DMSO; Sigma) and the control
culture was exposed to a culture medium containing 0.1%
DMSO.
Construction of shRNA expression vectors
Human  ERα gene sequence-specific shRNA expres-
sion vector, piERα was constructed by iGENE (Tokyo,
Japan) using piGENE-PUR-hU6 with resistant character-
istics of ampicillin and puromycin. The piERα shRNA se-
quence was as follows: 5'-TTGTGTTTCAACATTCTCC-3'
(the target sequence is located in the exon 4 of ERα cDNA).
Cell proliferation assays
In this study, we employed ER-positive human breast
cancer cell lines MCF-7 and BT474 which have been shown
to transiently induce the expression of EGFR mRNA and
protein because they were estrogen responsive [30]. BT474
cells were chosen as the less responsive ones to estrogen
stimulation. MCF-7 was kindly provided by Dr. Ichirou
Mori (Wakayama Medical University, Wakayama, Japan),
and BT474 was purchased from the American Type Culture
Collection (ATCC, Rockville, MD, USA). They were grown
in Dulbecco’s modified Eagle’s medium (GIBCO, Carlsbad,
CA, USA) containing 10% fetal bovine serum. Twenty-four
hr before treatment, cell culture medium was replaced with
phenol red-free Dulbecco’s modified Eagle’s medium
(GIBCO) containing 10% dextran-coated charcoal treated
fetal bovine serum. MCF-7 and BT474 cells were seeded
into 24-well plates at a density of 2×104 cells/well and
cultured further with or without 10−10~10−6 M of E2,
10−10~10−6 M of DES, or 10−8~10−4 M of BPA for 96 hr,
and then the cell number was measured with the cell count-
ing kit-8 (Dojindo, Kumamoto, Japan).
ERα gene silencing in MCF-7 cells using RNAi
MCF-7 cells were transfected with piERα vector or
empty vector. Twenty-four hr before transfection, cell cul-
ture medium was replaced with phenol red-free Dulbecco’s
modified Eagle’s medium (GIBCO) containing 10%
dextran-coated charcoal treated fetal bovine serum. The cells
were transfected with 2 μg of indicated plasmids using 5 μl
of FuGENE HD transfection regent (Roche, Indianapolis,
IN, USA). After 24 hr of transfection, the cells were cultured
with 2 μg/ml puromycin for 48 hr. At the end of incubation,
cells were washed with phosphate-buffered saline (PBS),
dead cells were removed from culture flask. Living cells
were seeded in 24-well plates at density of 5×104 and cul-
tured further with or without 10−10~10−6 M of E2, 10−10~10−6
M of DES, or 10−8~10−4 M of BPA for 96 hr.
Real-time RT-PCR
Total cellular RNA was isolated by the SV Total RNA
Isolation System (Promega, Madison, WI, USA) according
to the manufacturer’s recommended protocol. One μg of
total RNA was converted to double-stranded cDNA using
QuantiTect Reverse Transcription Kit (Qiagen, Valencia,
CA, USA). Real-time RT-PCR analysis was done using a
DNA Opticon system (MJ Research, Waltham, MA, USA).
The level of ERα expression was normalized relative to that
of the internal control, the β-actin gene. The reaction
protocol consisted of the following cycles: 95°C for 10 min,
40 cycles of 94°C for 10 sec, 60°C for 15 sec, and 72°C for
15 sec, followed by 72°C for 5 min. Primers for PCR
amplification were as follows: ERα forward, 5'-TGGAG
ATCTTCGACATGCTG-3'/reverse 5'-TCCAGAGACTTC
AGGGTGCT-3', β-actin, 5'-CCCAGCACAATGAAGATC
AA-3'/reverse, 5'-ACATCTGCTGGAAGGTGGAC-3'.
Immunocytochemistry
For immunostaining of ERα, the cells were cultured in
two-well permanox slides, and were washed with PBS and
fixed by 10% buffered formalin for 30 min. Cells were
pretreated by boiling in Target Retrieval solution High pH
(DAKO, Glostrup, Denmark) for 40 min. After peroxidase
activity was blocked with 0.03% H2O2 for 15 min, cells
were treated consecutively at room temperature with mouse
anti-ERα (1D5; DAKO) diluted at 1:50 for 1 hr, and the
signal was amplified with DAKO ENVISION+ kit (DAKO)
according to the manufacturer’s recommendations. Im-
munoreactivity was visualized by incubation with 3,3'-
diaminobenzidine tetrahydrochloride. Finally, cells were
counterstained with hematoxylin.
MIB-1 labeling index assay
Intact MCF-7 cells, empty vector transfected-MCF-7The Influence of EDCs on ERα-Knockdown MCF-7 25
cells and ERα-knockdown MCF-7 cells were incubated with
either BPA 10−5 M or vehicle control (0.1% DMSO) in cell-
chamber for 96 hr. At the end of incubation, the cells were
washed with PBS and fixed by 10% buffered formalin for
30 min. Endogenous peroxidase activity was blocked with
0.03% H2O2 for 15 min, and cells were permeabilized (0.4%
Tween20, 1% normal horse serum in PBS for 1 hr) and then
incubated for 1 hr at room temperature with mouse anti-
Ki-67 (MIB-1; DAKO) diluted at 1:50. The signal was
amplified with DAKO ENVISION+ kit (DAKO) according
to the manufacturer’s recommendations. Immunoreactivity
was visualized by incubation with 3,3'-diaminobenzidine
tetrahydrochloride. Finally, cells were counterstained with
hematoxylin. The MIB-1 LI was defined as the percent-
age of immunostained cells divided by the total number of
cells in the evaluated area. All counts were performed at a
magnification of ×400 using an ocular graticule consisting
of 10×10=100 fields covering an area of 0.0625 mm2. Ten
viable fields from the area of maximal labeling were
chosen for counting. A thousand to 5000 cells were counted
from each specimen.
Statistical analysis
Data are presented as means±standard deviation (SD)
of more or three independent experiments. The differences
between each treated value were evaluated by analysis of
variance and Student’s t-test. P<0.05 was considered statis-
tically significant.
III. Results
Cell proliferation analysis of intact MCF-7 cells and BT474 
cells
The human breast cancer MCF-7 and BT474 cells were
treated for 96 hr with a concentration of 10−10 M~10−6 M of
E2, 10−10 M~10−6 M of DES or 10−8 M~10−4 M of BPA. In
the cell proliferation of MCF-7, a significant increase was
detectable at concentration of 10−10 M~10−6 M of E2, 10−10
M~10−6 M of DES and 10−6 M and 10−5 M of BPA as com-
pared with vehicle groups (0.1% DMSO) (Fig. 1). In the cell
proliferation of BT474, a significant increase was not detect-
ed in any dose of E2-, DES- and BPA-treated groups com-
pared with vehicle groups (0.1% DMSO) (Fig. 1). The ex-
pression level of ERα of MCF-7 and BT474 were examined
by real-time RT-PCR and immunocytochemistry analysis
(Fig. 2), the MCF-7 ERα mRNA was highly expressed ap-
proximately 2.6-fold compared with BT474; these results
were further supported by immunocytochemistry analysis.
Effects of E2, DES and BPA on cell proliferation in ERα-
knockdown MCF-7 cells using RNAi
First, we evaluated the effect of RNAi-mediated knock-
down of ERα; the degree of knockdown was assessed by
real-time RT-PCR and immunocytochemistry analysis.
Transfection of the ERα shRNA expression vector was
observed to be significantly decreased by 3.1-fold com-
pared with empty vector-transfected MCF-7; these results
were further supported by immunocytochemistry analysis
(Fig. 3). The cell proliferation of ERα-knockdown MCF-7
was not detected in any dose of E2, DES and BPA (Fig. 4).
As another index for the cell proliferation activity, MIB-1 LI
was analyzed by Ki-67 immunohistochemistry. The MIB-1
LI of intact MCF-7 (1.8±0.07-fold) and empty vector-
transfected MCF-7 (2.4±0.1-fold) with 10−5 M of BPA
were significantly increased as compared with vehicle-
treated groups. In contrast, the MIB-1 LI of ERα-knock-
down MCF-7 showed no change in BPA-treated groups
(0.9±0.3-fold) (Fig. 5).
IV. Discussion
The biological effects of BPA have been widely studied
over the past several decades. It has been reported that BPA
can exert some of its effects by binding at the ERα or ERβ
to induce estrogenic signals that modify estrogen-responsive
gene expression [7, 10, 12]. However, in vitro effects of
BPA might be different in individual cell types, including
possible ER-independent actions [23, 27]. Although a major
Fig. 1. Effects of E2, DES and BPA on the cell proliferation in (A)
MCF-7 cells and (B) BT474 cells. Cells were treated with the indi-
cated concentrations of (closed square) E2, (closed triangle) DES or
(closed circle) BPA for 96 hr, and then the cell number was
counted. Bars indicate mean±SD values (n=3). Data are expressed
as fold change from vehicle control.Miyakoshi et al. 26
mechanism of BPA action is ER-regulated gene expression
through the estrogen responsive element (ERE), high con-
centrations of BPA could regulate expression of growth- and
development-related genes different from E2 in MCF-7 cells
stably expressing HA-tagged ERα [24], indicating that BPA
is unique in estrogen-dependent cell proliferation compared
to other EDCs. In the present study, we demonstrated that
the proliferation effects were induced in exposure of MCF-7
to BPA, which were dependent on the presence of functional
ERα as well as E2- and DES-action.
The MCF-7 cell line is a human breast cancer cell line
which possesses ERs and has been widely used as valuable
materials in environmental toxicology. As shown in
Figure 1, BPA-treated MCF-7 cells were shown to have
lower cell proliferation in comparison to E2 and DES, but
cell proliferation was not observed in BT474 cells with these
stimuli. The effective doses of these EDCs were consistent
with previous evidence [8, 20, 22]. To examine the reason
for differential effects of cell proliferation between MCF-7
cells and BT474 cells, the ERα expression level was exam-
ined by real-time RT-PCR and immunocytochemical analy-
sis. It was shown that the proliferative effects to these EDCs
were correlated with ERα content between MCF-7 cells and
BT474 cells, suggesting that regulation of ERα concentra-
tion may be a key component in estrogen responsiveness of
target cells. Therefore, in this study, to investigate whether
ERα is essential to the BPA-induced cell proliferation as
well as E2 and DES, we carried out specific inhibition of the
ERα gene using RNAi mediated by ERα-shRNA vector in
MCF-7. As shown in Figure 4, we found that the cell prolif-
eration of MCF-7 with BPA, E2 and DES was obviously in-
hibited by knockdown of ERα. As another index for the cell
proliferation activity, the Ki-67 antigen is widely known as
a cell growth marker [4, 26]. MIB-1 LI of ERα-knockdown
MCF-7 cells showed no change by incubation with BPA. It
is possible that ERα-mediated gene expression results in the
BPA-induced cell proliferation of MCF-7. On the other
hand, BPA was shown to exert both agonistic and antagonis-
tic effects through ERα while behaving exclusively as an
agonist through ERβ [7]. Although intact MCF-7 expressed
Fig. 2. The difference of ERα mRNA expression levels between
MCF-7 cells and BT474 cells by (A) real-time RT-PCR and (B)
immunocytochemistry. Real-time RT-PCR analysis was normal-
ized by those of β-actin as an internal standard. Data are expressed
as fold change from BT474 cells. * P<0.01. Original magnification:
×50. Bar=100 μm.
Fig. 3. The efficacy of ERα-knockdown by RNAi was confirmed
according to (A) real-time RT-PCR and (B) immunocytochemistry
analysis. Real-time RT-PCR normalized by those of β-actin as an
internal standard. Data are expressed as fold change from empty
vector-transfected MCF-7. * P<0.05. Original magnification: ×50.
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both ERα and ERβ in our studies, the BPA-induced cell pro-
liferations were inhibited only by ERα-knockdown, sug-
gesting that ERβ plays no important role in BPA-induced
cell proliferation, but this remains to be further investigated.
In this study, we carried out specific inhibition of the
ERα gene using RNAi mediated by ERα-shRNA vector in
MCF-7 for the following reasons. It has been reported that
specific gene silencing using shRNA-expressed vector can
provided stable suppression of a target gene by antibiotic
selection in mammalian cells [14, 19]. Indeed, immunocy-
tochemical analysis in our study showed that a reduction of
ERα was observed in ERα-shRNA vector, but not in control
vector. It was shown that gene suppression by shRNA vector
was a useful method for long-term estrogenicity tests. How-
ever, the ERα expressions were not completely inhibited in
ERα-knockdown MCF-7 cells, and few ERα expressions
were observed in the cytoplasm of these cells (as shown in
Fig. 3B). It may be due to low transfection efficiency of
piERα shRNA vector in MCF-7 cells.
In conclusion, we demonstrated that ERα has an impor-
tant role in BPA-induced cell proliferation, as well as E2 and
DES. Moreover, this study indicated that the knockdown of
ERα using RNAi serves as additional tool for evaluating, in
parallel with E-screen assay, for potential EDCs.
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